MaxCyte, Inc. (MXCT) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $0.88 (+0.01%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2025 | Mark Massaro | BTIG | $6.00 | +581.7% |
| Mar 13, 2024 | Mark Massaro | BTIG | $8.00 | +809.0% |
| Aug 14, 2022 | Mark Massaro | BTIG | $11.00 | +1149.9% |
Top Analysts Covering MXCT
MXCT vs Sector & Market
| Metric | MXCT | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +581.7% | +1149.5% | +14.9% |
| P/E Ratio | -2.09 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $31M | $31M | $31M | 5 |
| 2027-12-31 | $36M | $37M | $39M | 5 |
| 2028-12-31 | $38M | $39M | $40M | 2 |
| 2029-12-31 | $79M | $82M | $84M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.26 | $-0.26 | $-0.26 | 3 |
| 2027-12-31 | $-0.26 | $-0.25 | $-0.24 | 3 |
| 2028-12-31 | $-0.25 | $-0.24 | $-0.23 | 1 |
| 2029-12-31 | $-0.11 | $-0.11 | $-0.11 | 1 |
Frequently Asked Questions
What is the analyst consensus for MXCT?
The consensus among 1 analysts covering MaxCyte, Inc. (MXCT) is Buy with an average price target of $6.00.
What is the highest price target for MXCT?
The highest price target for MXCT is $11.00, set by Mark Massaro at BTIG on 2022-08-14.
What is the lowest price target for MXCT?
The lowest price target for MXCT is $6.00, set by Mark Massaro at BTIG on 2025-03-12.
How many analysts cover MXCT?
1 analysts have issued ratings for MaxCyte, Inc. in the past 12 months.
Is MXCT a buy or sell right now?
Based on 1 analyst ratings, MXCT has a consensus rating of Buy (2.00/5) with a +581.7% upside to the consensus target of $6.00.
What are the earnings estimates for MXCT?
Analysts estimate MXCT will report EPS of $-0.26 for the period ending 2026-12-31, with revenue estimated at $31M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.